Milestone Scientific Inc. MLSS

Company Overview

Milestone Scientific Inc. (NYSE American: MLSS) is a medical technology company focused on the development and commercialization of computerized drug delivery instruments designed to improve the precision, safety, and patient comfort of injections. The company operates primarily in the healthcare and medical device industries, with a concentration in dental anesthetic delivery systems and epidural injection technologies used in pain management and medical diagnostics. Its core value proposition centers on proprietary computer-controlled injection technologies intended to reduce procedural discomfort and improve practitioner control during injections.

The company’s principal revenue drivers include sales of disposable handpieces, instruments, and related consumables associated with its proprietary delivery platforms. Its flagship technologies include the dental-focused CompuDent and STA Single Tooth Anesthesia System platforms, as well as the CompuFlo Epidural System used in medical applications. Milestone Scientific serves dental practitioners, pain management specialists, hospitals, clinics, and healthcare distributors across domestic and international markets. The company traces its origins to the commercialization of computer-assisted injection systems in the dental sector and later expanded into medical applications involving epidural space identification and precision-controlled fluid delivery.

Business Operations

Milestone Scientific conducts operations through two principal business areas: its dental business and its medical business. The dental segment markets computerized local anesthetic delivery systems that are intended to improve injection accuracy and patient comfort during dental procedures. The medical segment focuses on the CompuFlo Epidural System, a technology platform designed to assist clinicians in identifying the epidural space during epidural procedures. Revenue is generated through the sale of capital equipment, disposable consumables, and related accessories distributed through direct channels and third-party distributors.

The company maintains operations primarily in the United States, while also supporting international distribution relationships across parts of Europe, Asia, the Middle East, and Latin America. Milestone Scientific’s intellectual property portfolio includes patents related to pressure sensing and computer-controlled fluid delivery technologies. The company has historically worked with distribution and commercialization partners to expand market penetration, particularly in the dental market. Public disclosures identify Milestone Medical Inc. as a significant subsidiary focused on medical applications and commercialization efforts related to epidural technologies.

Strategic Position & Investments

Milestone Scientific’s strategic direction has focused on expanding adoption of its proprietary injection technologies beyond dentistry into broader medical applications, particularly anesthesiology and pain management. A major emphasis has been placed on increasing clinical utilization of the CompuFlo Epidural System, which the company positions as a tool to improve procedural consistency during epidural injections. The company has supported this strategy through clinical studies, physician education initiatives, and efforts to secure broader institutional acceptance within hospitals and ambulatory care settings.

The company has also pursued investments in intellectual property development, regulatory clearances, and commercialization infrastructure. Its growth strategy has included strengthening recurring revenue from disposable components associated with its delivery systems. Public filings and investor materials indicate continued focus on expanding distributor relationships and increasing penetration in underserved international markets. While Milestone Scientific has explored broader medical applications for its technology platform, certain commercialization timelines and adoption projections remain dependent on regulatory, reimbursement, and market acceptance factors.

Geographic Footprint

Milestone Scientific is headquartered in Roseland, New Jersey, United States, and maintains a commercial footprint that spans multiple international markets through distributors and strategic commercial partners. The company’s largest operational presence remains in North America, particularly within the U.S. dental market, where its anesthetic delivery systems have been marketed for many years.

Internationally, the company has reported sales and distribution activity across regions including Europe, Asia-Pacific, Latin America, and the Middle East. Its medical technology initiatives, particularly those involving epidural systems, have also been evaluated or promoted in select international healthcare systems. The company’s global strategy relies heavily on third-party distribution networks rather than large-scale owned manufacturing or direct operational facilities abroad.

Leadership & Governance

Milestone Scientific is governed by a board of directors and executive leadership team focused on medical device commercialization, clinical adoption, and technology development. The company’s leadership strategy has emphasized expansion of proprietary injection technologies into broader healthcare applications while maintaining its established position in computerized dental anesthetic delivery systems.

Key executives and leadership figures include:

• Arjan Haverhals – Chief Executive Officer and President
• Leonard Osser – Chairman of the Board
• David Waldman – Chief Financial Officer
• Igor V. Gonda, Ph.D. – Director
• Leslie Bernhard, M.D. – Director

Company leadership has consistently communicated a strategy centered on advancing precision drug delivery technologies, pursuing clinical validation, and expanding recurring revenue opportunities tied to consumable medical products. Public disclosures, including SEC filings and investor communications, emphasize operational discipline, regulatory compliance, and commercialization growth within both the dental and medical business segments.